Market Place
Sourcing Support
Siren Biotech Reveals SRN-101 as Lead for High-Grade Gliomas
18 Nov 2024 //
GLOBENEWSWIRE
Merck Names Siren Biotechnology As North American Advance Biotech Grant Winner
04 Jun 2024 //
PRESS RELEASE
MilliporeSigma: Siren Bio Wins N.America Advance Biotech Grant
04 Jun 2024 //
BUSINESSWIRE
Siren Biotechnology, Catalent Partner for Manufacturing of AAV Gene Therapies
17 May 2024 //
PRESS RELEASE
Siren, Catalent Partner For AAV Cancer Gene Therapy Manufacturing
08 May 2024 //
GLOBENEWSWIRE
Siren Biotechnology Awarded $4M in Grant Funding from CIRM
01 Nov 2023 //
GLOBENEWSWIRE
ASGCT 2023: New preclinical updates from Tessera, Tune and more
23 May 2023 //
FIERCE BIOTECH
Siren wants gene therapy, cancer to `get into the weeds`
18 May 2023 //
FIERCE BIOTECH
Siren Bio Launches to Pioneer Universal AAV Immuno-Gene Therapy for Cancer
17 May 2023 //
GLOBENEWSWIRE
Siren Unveils Preclinical Data for Universal AAV Immuno-Gene Therapy for Cancer
17 May 2023 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.